InvestorInvesting in the future of life sciences and technology.

Eisai Innovation Inc. is the corporate venture capital arm of Eisai Co., Ltd., focusing on investments in innovative biotech and digital health companies. Established in 2019, it operates globally with a strategic emphasis on neurology and oncology.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Eisai Innovation Inc. (EII) is a strategic investment organization founded in 2019 and based in the United States. It aims to identify synergies between the scientific community and the Eisai network of companies. The organization focuses on creating a world free from the fear and pain of disease by acquiring innovative assets and businesses, collaborating with biotech and digital health companies, and establishing a global Corporate Venture Investment (CVI) capability. EII invests in the fields of neurology and oncology, including their digital solutions and diagnostics, targeting investments of approximately $5 million USD each, with a typical investment period of around 10 years for exit.
Eisai Innovation Inc. invests primarily in the fields of neurology and oncology, including their digital solutions and diagnostics. The organization targets investments of approximately $5 million each and operates globally, with a focus on regions such as the US, Europe, Japan, China, and emerging markets including Africa.
Eisai Innovation Inc. adds value to its portfolio companies by leveraging the extensive Eisai network, providing strategic guidance, and facilitating collaborations within the healthcare ecosystem to enhance innovation and market reach.
Superscout Pro
Is this page right?Reviewed · How the research works